Radiotherapy with or without temozolomide in elderly patients aged >= 70 years with glioblastoma
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.20, no.3, pp.251-255, 2016 (ESCI, Scopus)
- Publication Type: Article / Article
- Volume: 20 Issue: 3
- Publication Date: 2016
- Doi Number: 10.5114/wo.2016.61569
- Journal Name: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
- Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
- Page Numbers: pp.251-255
- Open Archive Collection: AVESIS Open Access Collection
- Eskisehir Osmangazi University Affiliated: Yes
Abstract
Introduction: Although the recommended optimal treatment of glioblastoma multiforme (GBM) is adjuvant chemoradiotherapy, trials in GBM have excluded patients older than 70 years. In this study, we aimed to assess overall survival (OS) and prognostic factors in elderly patients (>= 70 years) with newly diagnosed GBM treated with radiotherapy (RT) +/- concurrent/adjuvant temozolomide (TMZ).